BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Senti Bio to Present at Chardan’s 9th Annual Genetic Medicines Conference

  October 17, 2025

   · 

  2 min read
• Press Releases

  SCIENTURE’S Arbli™ Becomes First FDA-Approved Ready-to-Use Liquid Losartan Available Through Major U.S. Wholesalers

  October 17, 2025

   · 

  8 min read
• Press Releases

  Repair Biotechnologies Announces Appointment of Noted Endocrinologist Prof. Frederick J. Raal to Scientific Advisory Board

  October 17, 2025

   · 

  2 min read
• Press Releases

  Nanopath Expands Leadership Team to Drive Next Phase of Scientific and Commercial Growth

  October 17, 2025

   · 

  4 min read
• Press Releases

  Lexogen Launches miRVEL Profiling Small RNA-Seq Kit for Streamlined and Cost-Efficient sRNA Expression Analysis

  October 17, 2025

   · 

  2 min read
• Press Releases

  Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™

  October 17, 2025

   · 

  16 min read
• Press Releases

  Personalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing

  October 17, 2025

   · 

  4 min read
• Press Releases

  Cycle Pharmaceuticals Launches Its First Oncology Product, PHYRAGO™ (dasatinib) Tablets, in the US

  October 17, 2025

   · 

  8 min read
• Press Releases

  IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

  October 17, 2025

   · 

  3 min read
• Press Releases

  ME Therapeutics Granted Licence for CD22 Nanobody Asset to Expand Next-Gen In Vivo CAR Cell Therapy Program

  October 17, 2025

   · 

  6 min read